Metlife (MET) Earns News Impact Rating of 2.50

Press coverage about Metlife (NYSE:MET) has trended positive recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by monitoring more than 6,000 news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Metlife earned a media sentiment score of 2.50 on their scale. InfoTrie also assigned media stories about the financial services provider an news buzz score of 8 out of 10, meaning that recent press coverage is very likely to have an effect on the company’s share price in the near future.

Here are some of the news stories that may have impacted Metlife’s ranking:

Several equities research analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Metlife from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research report on Friday, October 5th. UBS Group increased their price objective on shares of Metlife from $48.00 to $49.00 and gave the stock a “neutral” rating in a research report on Monday, October 8th. Wells Fargo & Co reiterated a “buy” rating and set a $60.00 price objective on shares of Metlife in a research report on Thursday, September 27th. Credit Suisse Group cut their target price on shares of Metlife from $67.00 to $63.00 and set an “outperform” rating on the stock in a research note on Friday, August 17th. Finally, Morgan Stanley increased their target price on shares of Metlife from $52.00 to $54.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 13th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $53.92.

Metlife stock opened at $44.63 on Monday. Metlife has a 1-year low of $39.31 and a 1-year high of $55.21. The firm has a market capitalization of $44.04 billion, a price-to-earnings ratio of 9.92, a price-to-earnings-growth ratio of 0.66 and a beta of 1.28. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.14 and a current ratio of 0.14.

Metlife (NYSE:MET) last released its quarterly earnings data on Thursday, November 1st. The financial services provider reported $1.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. Metlife had a net margin of 7.62% and a return on equity of 9.76%. The firm had revenue of $16.40 billion for the quarter, compared to analyst estimates of $15.88 billion. During the same period last year, the firm earned $1.09 earnings per share. The business’s quarterly revenue was down 2.2% compared to the same quarter last year. Equities research analysts predict that Metlife will post 5.35 EPS for the current year.

Metlife declared that its board has authorized a share repurchase plan on Thursday, November 1st that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to repurchase up to 4.6% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Tuesday, November 6th will be paid a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.76%. The ex-dividend date of this dividend is Monday, November 5th. Metlife’s dividend payout ratio (DPR) is 37.33%.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Story: Why is the Consumer Price Index (CPI) important?

Insider Buying and Selling by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with's FREE daily email newsletter.

Leave a Reply